Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc De Hert

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Expert Opinion on Drug Safety|March 18, 2016
Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature reviewMarc De Hert, Johan Detraux, Brendon Stubbs
Psychopathology|February 1, 2014
Creativity and psychopathology: a systematic reviewErik Thys, Bernard Sabbe, Marc De Hert
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safetyJ Peuskens Marc De Hert Michael Jones
European Psychiatry : the Journal of the Association of European Psychiatrists|March 3, 2025
Prevalence, nature, and determinants of COVID-19-related conspiracy theories among healthcare workers: a scoping reviewHanne Loyens, Johan Detraux, Marc De Hert
European Psychiatry : the Journal of the Association of European Psychiatrists|February 10, 2025
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative reviewKirsten Catthoor, Johan Detraux, Marc De Hert
International Clinical Psychopharmacology|April 7, 2007
Metabolic control in patients with schizophrenia treated with amisulpride or olanzapineJoseph Peuskens, Marc De Hert, Ann Mortimer, et al.
Clinical Case Reports|December 3, 2019
The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic reviewThomas Van der Poorten, Marc De Hert
Current Pharmaceutical Design|June 20, 2015
Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental IllnessYoussef Kouidrat, Ali Amad, Marc De Hert
Dialogues in Clinical Neuroscience|June 28, 2018
The intriguing relationship between coronary heart disease and mental disordersMarc De Hert, Johan Detraux, Davy Vancampfort
Expert Opinion on Drug Safety|April 5, 2014
Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature reviewMarc De Hert, Johan Detraux, Joseph Peuskens
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Expert Opinion on Drug Safety|March 18, 2016
Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature reviewMarc De Hert, Johan Detraux, Brendon Stubbs
Psychopathology|February 1, 2014
Creativity and psychopathology: a systematic reviewErik Thys, Bernard Sabbe, Marc De Hert
International Journal of Psychiatry in Clinical Practice|June 14, 2014
The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safetyJ Peuskens Marc De Hert Michael Jones
European Psychiatry : the Journal of the Association of European Psychiatrists|March 3, 2025
Prevalence, nature, and determinants of COVID-19-related conspiracy theories among healthcare workers: a scoping reviewHanne Loyens, Johan Detraux, Marc De Hert
European Psychiatry : the Journal of the Association of European Psychiatrists|February 10, 2025
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative reviewKirsten Catthoor, Johan Detraux, Marc De Hert
International Clinical Psychopharmacology|April 7, 2007
Metabolic control in patients with schizophrenia treated with amisulpride or olanzapineJoseph Peuskens, Marc De Hert, Ann Mortimer, et al.
Clinical Case Reports|December 3, 2019
The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: A systematic reviewThomas Van der Poorten, Marc De Hert
Current Pharmaceutical Design|June 20, 2015
Emerging Drugs and Indications for Cardio-Metabolic Disorders in People with Severe Mental IllnessYoussef Kouidrat, Ali Amad, Marc De Hert
Dialogues in Clinical Neuroscience|June 28, 2018
The intriguing relationship between coronary heart disease and mental disordersMarc De Hert, Johan Detraux, Davy Vancampfort
Expert Opinion on Drug Safety|April 5, 2014
Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature reviewMarc De Hert, Johan Detraux, Joseph Peuskens
Pageof 26